NASDAQ: ARCTArcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?
Insider buying vs selling
Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Pad Chivukula | Chief Scientific Officer & COO | 2022-01-04 | 8,100 | $40.00 | $324.00kSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-12-16 | 3,633 | $40.00 | $145.33kSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-12-08 | 6,367 | $40.00 | $254.68kSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-11-01 | 10,000 | $44.41 | $444.10kSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-10-01 | 10,000 | $44.36 | $443.60kSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-09-01 | 10,000 | $55.86 | $558.60kSell |
| Ultragenyx Pharmaceutical Inc | Director | 2021-08-11 | 75,000 | $45.83 | $3.44MSell |
| Ultragenyx Pharmaceutical Inc | Director | 2021-08-10 | 725,000 | $55.44 | $40.19MSell |
| Pad Chivukula | Chief Scientific Officer & COO | 2021-08-03 | 10,000 | $40.07 | $400.70kSell |
ARCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
ARCT Shareholders
What type of owners hold Arcturus Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Federated Hermes Inc | 14.24% | 3,761,900 | $60.72M | Institution |
| State Street Corp | 12.18% | 3,217,957 | $51.94M | Institution |
| Ark Investment Management LLC | 9.02% | 2,383,840 | $38.48M | Institution |
| Blackrock Inc | 6.42% | 1,695,639 | $27.37M | Institution |
| Joseph E. Payne | 5.58% | 1,475,097 | $23.81M | Insider |
| Sumitomo Mitsui Trust Holdings Inc | 5.31% | 1,402,078 | $22.63M | Institution |
| Nikko Asset Management Americas Inc | 5.31% | 1,402,078 | $22.63M | Institution |
| Ultragenyx Pharmaceutical Inc | 5.30% | 1,400,000 | $22.60M | Insider |
| Vanguard Group Inc | 4.37% | 1,153,513 | $18.62M | Institution |
| Fmr LLC | 3.49% | 920,796 | $14.86M | Institution |
ARCT vs Biotech Stocks
Arcturus Therapeutics Holdings Stock Ownership FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.